Means to detect whether acute hepatopancreatic necrosis disease-causing vibrio parahaemolyticus is virulent or non-virulent

US12442817B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12442817-B2
Application numberUS-202017641402-A
CountryUS
Kind codeB2
Filing dateSep 10, 2020
Priority dateSep 12, 2019
Publication dateOct 14, 2025
Grant dateOct 14, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of monitoring acute hepatopancreatic necrosis disease in shrimp is disclosed. More specifically, detection of the presence of alkaline phosphatase Phox enzyme, or, of the PiRAVP and/or the PirBVP toxins of acute hepatopancreatic necrosis disease-causing Vibrio parahaemolyticus correlates with non-virulence or virulence, respectively, of the bacterium is disclosed. Hence, an assay capable of detecting the Phox enzyme and/or the toxins could be very useful to monitor the disease in shrimp.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of phenotyping Vibrio parahaemolyticus as non-virulent, the method comprising: providing a sample comprising shrimp culture water; utilizing antibodies or fragments thereof that bind to alkaline phosphatase Phox enzyme of V. parahaemolyticus to phenotype the V. parahaemolyticus as non-virulent; and culturing the shrimp without disease-mitigation treatment if the V. parahaemolyticus are phenotyped as non-virulent. 2. The method according to claim 1 , whereby acute hepatopancreatic necrosis disease in shrimp is monitored. 3. An assay comprising: antibodies or fragments thereof that bind to the alkaline phosphatase Phox enzyme of Vibrio parahaemolyticus. 4. A method of using the assay according to claim 3 to phenotype V. parahaemolyticus as non-virulent or as virulent, the method comprising: interacting the assay with a sample. 5. The assay according to claim 4 , wherein the assay is a lateral flow immunochromatographic assay or an enzyme-linked immunosorbent assay. 6. A process of phenotyping Vibrio parahaemolyticus as non-virulent, the process comprising: providing a sample comprising shrimp culture water; bringing the sample into contact with antibodies or fragments thereof that bind to alkaline phosphatase Phox enzyme of V. parahaemolyticus; determining whether the alkaline phosphatase Phox enzyme of V. parahaemolyticus is present in the sample; classifying the V. parahaemolyticus s non-virulent when the alkaline phosphatase Phox enzyme is present in the sample; and culturing the shrimp without disease-mitigation treatment upon classification of the V. parahaemolyticus as non-virulent. 7. The method according to claim 4 , wherein the assay is a lateral flow immunochromatographic assay or an enzyme-linked immunosorbent assay.

Assignees

Inventors

Classifications

  • acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4) · CPC title

  • from Vibrionaceae (F) · CPC title

  • G01N33/573Primary

    for enzymes or isoenzymes · CPC title

  • Bacteria · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12442817B2 cover?
A method of monitoring acute hepatopancreatic necrosis disease in shrimp is disclosed. More specifically, detection of the presence of alkaline phosphatase Phox enzyme, or, of the PiRAVP and/or the PirBVP toxins of acute hepatopancreatic necrosis disease-causing Vibrio parahaemolyticus correlates with non-virulence or virulence, respectively, of the bacterium is disclosed. Hence, an assay capab…
Who is the assignee on this patent?
Univ Gent
What technology area does this patent fall under?
Primary CPC classification G01N33/573. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).